Albulena Mecinaj

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol

Siri Lagethon Heck, Albulena Mecinaj, Anne Hansen Ree et al. · Circulation · 2021 · 137 citations · Full text

Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction

Albulena Mecinaj, Geeta Gulati, Anne Hansen Ree et al. · JACC CardioOncology · 2024 · 40 citations · Full text

Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity

Peder L. Myhre, Siri Lagethon Heck, Julia Brox Skranes et al. · American Heart Journal · 2021 · 36 citations · Full text

Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial

Albulena Mecinaj, Geeta Gulati, Espen Holte et al. · Cardio-Oncology · 2021 · 32 citations · Full text

Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID‐19

Tarjei Øvrebotten, Peder L. Myhre, Jostein Grimsmo et al. · Clinical Cardiology · 2022 · 21 citations · Full text